Phase 1/2CompletedAge-related condition
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
- Sponsor
- Nacuity Pharmaceuticals, Inc. (Industry)
- Enrolment
- 24 enrolled
- Conditions
- Cataract
- Interventions
- NPI-002 Intravitreal Implant
- Ages
- adults, older adults
- Registry
- NCT05026632
Full record on ClinicalTrials.gov
From the registry
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Primary outcomes
- Lens Densitometry
History
Last registry update
Primary completion
Started
Registered